Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for MDT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
July 31, 2026 15.16%
April 30, 2026 12.84%
January 31, 2026 12.75%
October 31, 2025 15.42%
July 31, 2025 12.21%
April 30, 2025 11.90%
January 31, 2025 15.71%
October 31, 2024 15.21%
July 31, 2024 13.24%
April 30, 2024 7.67%
January 31, 2024 16.53%
October 31, 2023 11.41%
July 31, 2023 10.35%
April 30, 2023 13.90%
January 31, 2023 15.91%
October 31, 2022 5.74%
July 31, 2022 12.63%
April 30, 2022 18.44%
January 31, 2022 19.10%
October 31, 2021 16.78%
July 31, 2021 9.63%
April 30, 2021 16.70%
January 31, 2021 16.45%
October 31, 2020 6.46%
July 31, 2020 7.55%
Date Value
April 30, 2020 10.67%
January 31, 2020 24.87%
October 31, 2019 17.79%
July 31, 2019 11.70%
April 30, 2019 14.51%
January 31, 2019 16.84%
October 31, 2018 14.97%
July 31, 2018 14.59%
April 30, 2018 17.99%
January 31, 2018 -18.89%
October 31, 2017 28.55%
July 31, 2017 13.65%
April 30, 2017 14.70%
January 31, 2017 11.26%
October 31, 2016 15.13%
July 31, 2016 12.96%
April 30, 2016 14.59%
January 31, 2016 15.79%
October 31, 2015 7.37%
July 31, 2015 11.27%
April 30, 2015 -0.01%
January 31, 2015 22.63%
October 31, 2014 18.96%
July 31, 2014 20.38%
April 30, 2014 9.81%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
STERIS Plc (Ireland) 13.47%
Abbott Laboratories 7.37%
Becton, Dickinson & Co. 9.05%
Boston Scientific Corp. 16.63%
Intuitive Surgical, Inc. 28.46%